Science Day at MUMC+ On April 2, Kjell van der Walle and Paul Kruithof gave a poster presentation during the Science Day at MUMC+
Paul presented the progress of the Osiboost 2A clinical trial (Trial in progress: Personalized Osimertinib dose adjustment and pharmacokinetic boosting to improve cost-effectiveness in advanced EGFR-mutated Non-Small Cell Lung Cancer treatment).
Kjell’s research, "The incidence of diuretic-associated sequential prescribing cascades: a feasibility study," focused on identifying prescribing cascades related to diuretics. Both presentations were well received and both speakers received excellent feedback on their research.